You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Clinical and demographic characteristics of participants (N = 730)

From: Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand

  Māori (N=241) Non-Māoria (N=489) Total (N=730)
Characteristics No. (%) No. (%) No. (%) Any HPV positive (%)
Histologically-confirmed CIN 2+ 153 (63) 287 (59) 440 (60) 423 (96)
Cervical cancerb 4 (2) 8 (2) 12 (2) 11 (92)
 High grade lesion 149 (62) 269 (55) 418 (57) 404 (97)
  CIN 2c 80 (33) 149 (30) 229 (31) 224 (98)
  CIN 3 69 (29) 120 (25) 189 (26) 180 (95)
  AIS or glandular dysplasia 0 (0) 10 (2) 10 (1) 8 (80)
Histologically-confirmed < CIN 2 75 (31) 186 (38) 261 (36) 232 (89)
 Low grade lesion 43 (18) 104 (21) 147 (20) 135 (92)
  CIN 1 20 (8) 66 (13) 86 (12) 76 (88)
  Other low grade abnormalityd 23 (10) 38 (8) 61 (8) 59 (97)
 Negative 32 (13) 82 (17) 114 (16) 97 (85)
  Negative/normal 19 (8) 38 (8) 57 (8) 51 (89)
  Other non-significant abnormalitye 13 (5) 44 (9) 57 (8) 46 (81)
No biopsy taken/reported 13 (5) 16 (3) 29 (4) 24 (83)
Age 20–29 years 121 (50) 214 (44) 335 (46) 328 (98)
Age 30–39 years 77 (32) 149 (30) 226 (31) 207 (92)
Age 40–69 years 43 (18) 126 (26) 169 (23) 144 (85)
  1. CIN cervical intraepithelial neoplasia, AIS adenocarcinoma in situ
  2. aWomen with unknown ethnicity were categorised as non-Māori
  3. bCervical cancer includes invasive adenocarcinoma, invasive squamous cell carcinoma, microinvasive squamous cell carcinoma, other primary epithelial malignancy and adenosquamous carcinoma
  4. cIncludes a total of 116 cases initially coded as CIN2/3 (i.e., M67017) in the National Cervical Screening Programme Register (NCSP-R); we re-classified according to the NCSP-R convention (see text)
  5. dHistological appearance infection with human papillomavirus (HPV), Condyloma acuminatum, Dysplasia/CIN not otherwise specified (NOS)
  6. eInflammation, squamous metaplasia, polyp, other